Morrow DA - Search Results

1

Sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction: a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF.

Vaduganathan M, Mentz RJ, Claggett BL, Miao ZM, Kulac IJ, Ward JH, Hernandez AF, Morrow DA, Starling RC, Velazquez EJ, Williamson KM, Desai AS, Zieroth S, Lefkowitz M, McMurray JJV, Braunwald E, Solomon SD. Vaduganathan M, et al. Among authors: morrow da. Eur Heart J. 2023 Aug 14;44(31):2982-2993. doi: 10.1093/eurheartj/ehad344. Eur Heart J. 2023. PMID: 37210743 Free PMC article. Clinical Trial.

2

Very early risk stratification after thrombolytic therapy with a bedside myoglobin assay and the 12-lead electrocardiogram.

De Lemos JA, Antman EM, Giugliano RP, Morrow DA, McCabe CH, Charlesworth A, Schröder R, Braunwald E. De Lemos JA, et al. Among authors: morrow da. Am Heart J. 2000 Sep;140(3):373-8. doi: 10.1067/mhj.2000.109216. Am Heart J. 2000. PMID: 10966533 Clinical Trial.

3

Comparison of a 60- versus 90-minute determination of ST-segment resolution after thrombolytic therapy for acute myocardial infarction. In TIME-II Investigators. Intravenous nPA for Treatment of Infarcting Myocardium Early-II.

de Lemos JA, Antman EM, Giugliano RP, Morrow DA, McCabe CH, Cutler SS, Charlesworth A, Schröder R, Braunwald E. de Lemos JA, et al. Among authors: morrow da. Am J Cardiol. 2000 Dec 1;86(11):1235-7, A5. doi: 10.1016/s0002-9149(00)01207-8. Am J Cardiol. 2000. PMID: 11090796 Clinical Trial.

4

Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy.

Morrow DA, Antman EM, Tanasijevic M, Rifai N, de Lemos JA, McCabe CH, Cannon CP, Braunwald E. Morrow DA, et al. J Am Coll Cardiol. 2000 Nov 15;36(6):1812-7. doi: 10.1016/s0735-1097(00)00942-6. J Am Coll Cardiol. 2000. PMID: 11092649 Free article.

5

Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial.

Morrow DA, Cannon CP, Rifai N, Frey MJ, Vicari R, Lakkis N, Robertson DH, Hille DA, DeLucca PT, DiBattiste PM, Demopoulos LA, Weintraub WS, Braunwald E; TACTICS-TIMI 18 Investigators. Morrow DA, et al. JAMA. 2001 Nov 21;286(19):2405-12. doi: 10.1001/jama.286.19.2405. JAMA. 2001. PMID: 11712935 Clinical Trial.

6

An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS.

Morrow DA, Antman EM, Snapinn SM, McCabe CH, Theroux P, Braunwald E. Morrow DA, et al. Eur Heart J. 2002 Feb;23(3):223-9. doi: 10.1053/euhj.2001.2738. Eur Heart J. 2002. PMID: 11792137 Clinical Trial.

7

Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide.

Sabatine MS, Morrow DA, de Lemos JA, Gibson CM, Murphy SA, Rifai N, McCabe C, Antman EM, Cannon CP, Braunwald E. Sabatine MS, et al. Among authors: morrow da. Circulation. 2002 Apr 16;105(15):1760-3. doi: 10.1161/01.cir.0000015464.18023.0a. Circulation. 2002. PMID: 11956114

8

Identification of patients at high risk for death and cardiac ischemic events after hospital discharge.

Sabatine MS, McCabe CH, Morrow DA, Giugliano RP, de Lemos JA, Cohen M, Antman EM, Braunwald E. Sabatine MS, et al. Among authors: morrow da. Am Heart J. 2002 Jun;143(6):966-70. doi: 10.1067/mhj.2002.122870. Am Heart J. 2002. PMID: 12075250 Clinical Trial.

9

Validation of the thrombolysis in myocardial infarction (TIMI) risk score for unstable angina pectoris and non-ST-elevation myocardial infarction in the TIMI III registry.

Scirica BM, Cannon CP, Antman EM, Murphy SA, Morrow DA, Sabatine MS, McCabe CH, Gibson CM, Braunwald E. Scirica BM, et al. Among authors: morrow da. Am J Cardiol. 2002 Aug 1;90(3):303-5. doi: 10.1016/s0002-9149(02)02468-2. Am J Cardiol. 2002. PMID: 12127617 No abstract available.

10

Minimal ST-segment deviation: a simple, noninvasive method for identifying patients with a patent infarction-related artery after fibrinolytic administration.

Cooper HA, de Lemos JA, Morrow DA, Sabatine MS, Murphy SA, McCabe CH, Gibson CM, Antman EM, Braunwald E. Cooper HA, et al. Among authors: morrow da. Am Heart J. 2002 Nov;144(5):790-5. doi: 10.1067/mhj.2002.125618. Am Heart J. 2002. PMID: 12422146

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

582 results

Search Page